It could be that the market is uncomfortable waiting for information that should have already been released.
So far being a development stage company the company has only revealed modest revenue. In Q2 and Q3 ORHB has had revenue of $25,000 and $37,000 respectively. As I look over the finances what stands out to me is the loss the company incurred in the 3rd quarter: ($9,423,000). They've not only spent a substantial amount of available cash on hand but they also took on $1.25 million in debt.
https://www.otcmarkets.com/stock/ORHB/financials
I guess the next financial statement will reveal if there are increasing revenues and how much they have managed to lower their overhead.
We should also be able to project some the financial health of the company by seeing their cash on hand and burn rate and such.
Watch for opportunities with those you trust.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM